MedPath

Umbilical Cord Serum Eye Drops

Not Applicable
Completed
Conditions
Recurrent Corneal Erosion
Interventions
Drug: Umbilical cord serum eyedrops
Registration Number
NCT01016158
Lead Sponsor
Chonnam National University Hospital
Brief Summary

In the present study, the investigators investigated the efficacy of umbilical cord serum eye drops for the treatment of patients with recurrent corneal erosions. Group A were treated with 20% umbilical cord serum eye drops 3 to 4 times a day in addition to artificial tears, and group B were treated with artificial tears only. Ophthalmic examinations including visual acuity measurement and slit lamp biomicroscopy were performed before and every month after treatment. Recurrence was defined as the presence of clinical symptoms accompanied by epithelial defects in the cornea.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • patients with recurrent corneal erosions
Read More
Exclusion Criteria
  • none
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
umbilical cord serum eyedropsUmbilical cord serum eyedropspatients with recurrent corneal erosions were treated with 20% umbilical cord serum eye drops 3 to 4 times a day in addition to artificial tears
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chonnam National University Hospital

🇰🇷

Gwang-Ju, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath